Choong Ang Vaccine Laboratory Co. Ltd

KQ:072020 Korea Drug Manufacturers - Specialty & Generic
Market Cap
$59.00 Million
₩86.38 Billion KRW
Market Cap Rank
#22262 Global
#1121 in Korea
Share Price
₩9230.00
Change (1 day)
-0.75%
52-Week Range
₩8780.00 - ₩10200.00
All Time High
₩30815.73
About

Choong Ang Vaccine Laboratory Co., Ltd. engages in the research, development, manufacturing, and sale of animal vaccines in South Korea, Asia, Africa, and the United States. It offers swine, poultry, cattle, canine, feline, wild boar, and raccoon vaccines under the SuiShot, PoulShot, BoviShot, CaniShot, and FeliShot brands. The company was founded in 1968 and is headquartered in Daejeon, South Ko… Read more

Choong Ang Vaccine Laboratory Co. Ltd (072020) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of September 2025: 0.015x

Based on the latest financial reports, Choong Ang Vaccine Laboratory Co. Ltd (072020) has a cash flow conversion efficiency ratio of 0.015x as of September 2025.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩1.55 Billion) by net assets (₩104.72 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Choong Ang Vaccine Laboratory Co. Ltd - Cash Flow Conversion Efficiency Trend (2014–2024)

This chart illustrates how Choong Ang Vaccine Laboratory Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

Choong Ang Vaccine Laboratory Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Choong Ang Vaccine Laboratory Co. Ltd ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for Choong Ang Vaccine Laboratory Co. Ltd (2014–2024)

The table below shows the annual cash flow conversion efficiency of Choong Ang Vaccine Laboratory Co. Ltd from 2014 to 2024.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 ₩103.87 Billion ₩13.40 Billion 0.129x +1.35%
2023-12-31 ₩99.80 Billion ₩12.71 Billion 0.127x +71.24%
2022-12-31 ₩95.30 Billion ₩7.09 Billion 0.074x -40.02%
2021-12-31 ₩92.98 Billion ₩11.53 Billion 0.124x +30.51%
2020-12-31 ₩87.55 Billion ₩8.32 Billion 0.095x -1.15%
2019-12-31 ₩86.37 Billion ₩8.30 Billion 0.096x +43.06%
2018-12-31 ₩85.00 Billion ₩5.71 Billion 0.067x -42.55%
2017-12-31 ₩64.68 Billion ₩7.56 Billion 0.117x -8.46%
2016-12-31 ₩60.37 Billion ₩7.71 Billion 0.128x -29.41%
2015-12-31 ₩54.88 Billion ₩9.93 Billion 0.181x +41.03%
2014-12-31 ₩51.99 Billion ₩6.67 Billion 0.128x --